This trial will test if providing HIV medicine immediately at an IDEA Syringe Services Program will help people with HIV get and stay in care, including having no detectable HIV in their blood.
- Human Immunodeficiency Virus (HIV) Infection
- Substance Use
0 Primary · 1 Secondary · Reporting Duration: 12 months
1 Treatment Group
Rapid ART group
1 of 1
50 Total Participants · 1 Treatment Group
Primary Treatment: HIV care · No Placebo Group · Phase 4
Who is running the clinical trial?
Age 18+ · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
What site did they apply to?
|University of Miami||100.0%|
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Most responsive sites:
- University of Miami: < 24 hours
Average response time
- < 1 Day
Frequently Asked Questions
Is this research initiative currently recruiting participants?
"Affirmative. Perusal of the information available on clinicaltrials.gov reveals that this experiment is presently recruiting candidates, beginning from March 4th 2021 and concluding on May 4th 2022. 50 participants are sought after in a single medical centre." - Anonymous Online Contributor
Are there any past studies that have focused on HIV treatment?
"Currently, 98 medical trials for HIV care are ongoing with the majority of Phase 3 studies located in Boylston, MA. Across 1610 sites worldwide these clinical experiments are being conducted." - Anonymous Online Contributor
What medical issues are typically treated with HIV care?
"Anti-retroviral agents are a major component of HIV care, and this type of treatment has been demonstrated to be effective for patients who have yet to receive medication, lack resistance to darunavir, or suffer from HIV-1." - Anonymous Online Contributor
How many participants have voluntarily joined this trial?
"Indeed, information hosted on clinicaltrials.gov indicates that this research trial is actively enrolling participants and was first posted on March 4th 2021. The study aims to recruit 50 patients from a single medical site." - Anonymous Online Contributor
To what extent does providing HIV care pose risks to individuals?
"The safety of HIV care has been verified in Phase 4 trials and thus earned a rating of 3." - Anonymous Online Contributor